Shanghai Haoyuan Chemexpress (688131.SH): Su Xin Fund plans to reduce its holdings by no more than 0.26% of its shares.
Hao Yuan Pharmaceuticals (688131.SH) announced that, due to the expiration of funds and financial needs of shareholders, Su Xin Fund intends to reduce its holdings of no more than 54,640 shares of the company's stock through centralized bidding, with a planned reduction percentage not exceeding 0.26% of the total current share capital of the company. The reduction plan will be carried out within 3 months after 3 trading days from the date of the announcement.
Shanghai Haoyuan Chemexpress (688131.SH) has announced that Su Xin Fund intends to reduce its holdings of the company's shares by no more than 546,400 shares through centralized bidding, due to the expiration of the fund and the shareholders' own financial needs. The planned reduction percentage will not exceed 0.26% of the company's current total share capital. The reduction plan will be implemented within 3 months after the announcement is made, starting from the third trading day after the disclosure of the announcement.
Related Articles

Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.

Industrial: Hong Kong stock market sentiment index has reached the bottom area.

"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"
Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.

Industrial: Hong Kong stock market sentiment index has reached the bottom area.

"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"

RECOMMEND

Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026

Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026

Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026


